BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 38646148)

  • 1. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine tuning of the net charge alternation of polyzwitterion surfaced lipid nanoparticles to enhance cellular uptake and membrane fusion potential.
    Homma K; Miura Y; Kobayashi M; Chintrakulchai W; Toyoda M; Ogi K; Michinishi J; Ohtake T; Honda Y; Nomoto T; Takemoto H; Nishiyama N
    Sci Technol Adv Mater; 2024; 25(1):2338785. PubMed ID: 38646148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ethylenediamine-based Switch to Render the Polyzwitterion Cationic at Tumorous pH for Effective Tumor Accumulation of Coated Nanomaterials.
    Ranneh AH; Takemoto H; Sakuma S; Awaad A; Nomoto T; Mochida Y; Matsui M; Tomoda K; Naito M; Nishiyama N
    Angew Chem Int Ed Engl; 2018 Apr; 57(18):5057-5061. PubMed ID: 29512262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing.
    Sarode A; Fan Y; Byrnes AE; Hammel M; Hura GL; Fu Y; Kou P; Hu C; Hinz FI; Roberts J; Koenig SG; Nagapudi K; Hoogenraad CC; Chen T; Leung D; Yen CW
    Nanoscale Adv; 2022 May; 4(9):2107-2123. PubMed ID: 36133441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive polyzwitterion covered nanocarriers for DNA delivery.
    Shen X; Dirisala A; Toyoda M; Xiao Y; Guo H; Honda Y; Nomoto T; Takemoto H; Miura Y; Nishiyama N
    J Control Release; 2023 Aug; 360():928-939. PubMed ID: 37495117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications.
    Qin J; Xue L; Gong N; Zhang H; Shepherd SJ; Haley RM; Swingle KL; Mitchell MJ
    RSC Adv; 2022 Sep; 12(39):25397-25404. PubMed ID: 36199352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stealth nanoparticles in oncology: Facing the PEG dilemma.
    Zalba S; Ten Hagen TLM; Burgui C; Garrido MJ
    J Control Release; 2022 Nov; 351():22-36. PubMed ID: 36087801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancerous pH-responsive polycarboxybetaine-coated lipid nanoparticle for smart delivery of siRNA against subcutaneous tumor model in mice.
    Sung YJ; Guo H; Ghasemizadeh A; Shen X; Chintrakulchai W; Kobayashi M; Toyoda M; Ogi K; Michinishi J; Ohtake T; Matsui M; Honda Y; Nomoto T; Takemoto H; Miura Y; Nishiyama N
    Cancer Sci; 2022 Dec; 113(12):4339-4349. PubMed ID: 36047963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the Endosomal Escape: A Closer Look at Calcein and Related Reporters.
    Hausig-Punke F; Richter F; Hoernke M; Brendel JC; Traeger A
    Macromol Biosci; 2022 Oct; 22(10):e2200167. PubMed ID: 35933579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature.
    Kong H; Yi K; Zheng C; Lao YH; Zhou H; Chan HF; Wang H; Tao Y; Li M
    J Mater Chem B; 2022 Sep; 10(36):6841-6858. PubMed ID: 35781483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changeable net charge on nanoparticles facilitates intratumor accumulation and penetration.
    Awaad A; Takemoto H; Iizuka M; Ogi K; Mochida Y; Ranneh AH; Toyoda M; Matsui M; Nomoto T; Honda Y; Hayashi K; Tomoda K; Ohtake T; Miura Y; Nishiyama N
    J Control Release; 2022 Jun; 346():392-404. PubMed ID: 35461967
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.